Long Periods Without Medical Device Adverse Event Reports May Become a Risk Indicator in Russia

Russia's Ministry of Health has proposed adding a new risk indicator to the system used by Roszdravnadzor for medical device oversight: an extended period during which a healthcare organization has not submitted any adverse event reports related to the use of medical devices. If a healthcare organization goes without reporting for longer than the applicable threshold — which varies by risk category — this could become grounds for Roszdravnadzor to initiate a closer regulatory review. As of September 2, 2026, the draft has not been formally adopted and the indicator is not yet in force. The proposed changes would amend the current list of risk indicators under Ministry of Health Order No. 368n of July 17, 2023.

The proposed indicator does not limit its scope to specific categories or risk classes of medical devices — it applies to adverse events related to the use of medical devices generally, across all types used within a healthcare organization. This means the indicator is relevant regardless of whether the device is a high-risk implant, a Class 2b diagnostic system, or a lower-risk product. For foreign manufacturers, the practical takeaway is that any medical device placed on the Russian market and used in clinical settings could in principle generate adverse event reports that feed into this monitoring chain.

The proposed thresholds vary by the healthcare organization's risk category assigned by Roszdravnadzor. For organizations in the extremely high-risk category, the threshold is more than one year without reports. For high-risk organizations, more than one and a half years. For significant-risk organizations, more than two years. For medium, moderate, and low-risk organizations, more than two and a half years. The period is counted from the moment the organization applies a medical device, provided that information is recorded in the Federal Register of Healthcare Organizations. This is not about requiring a fixed number of reports — it is a signal that prolonged silence may indicate problems with how adverse events are being identified, recorded, or transmitted internally.

No. A risk indicator is not proof of a violation — it is a predefined parameter that allows Roszdravnadzor to identify situations that may warrant closer attention within the risk-based oversight framework. When the indicator is triggered, an authorized official may prepare a reasoned submission proposing a supervisory measure. Whether a mandatory requirement has actually been violated can only be determined through a subsequent inspection or review. The indicator opens the door to regulatory attention — it does not establish non-compliance on its own. The experts at Unified Center of Expertise and Certification (UCEC Quality LLC) note that this distinction matters in practice: organizations that have a functioning adverse event reporting process in place are far better positioned to demonstrate compliance during any subsequent review than those who have not yet built that process.

An adverse event involving a medical device covers a broader range of situations than just cases where a patient has been harmed. It includes side effects not described in the instructions for use or operating manual, unwanted reactions during device use, interaction issues between medical devices, and any facts or circumstances that create a threat to the life or health of patients, healthcare workers, or other persons. This means the reporting obligation is not limited to clear-cut harm incidents — it also extends to situations that indicate a potential risk or a malfunction that could have caused harm, even if no injury actually occurred.

The obligation to submit adverse event reports is not new — it predates the proposed risk indicator. From September 1, 2026, Russia's updated medical device safety monitoring procedure is in force, which among other things specifies that reports must be submitted within 20 working days of identifying an adverse event, through Roszdravnadzor's automated information system. The proposed risk indicator is a separate layer built on top of this existing obligation: it gives Roszdravnadzor a formal tool to identify healthcare organizations that appear to have stopped reporting altogether. The two developments are connected — the reporting obligation creates the duty, and the proposed indicator creates a mechanism for identifying who may not be fulfilling it.

As of September 2, 2026, the proposed indicator is not yet in force. The Ministry of Health draft prepared on July 29, 2026 remains unsigned, which means there is no confirmed effective date. The indicator cannot be treated as an active requirement until the relevant order is formally adopted and published. However, the underlying obligation for healthcare organizations in Russia to submit adverse event reports already exists and has been reinforced by Russia's updated safety monitoring procedure that took effect on September 1, 2026.

From September 1, 2026, Russia's updated medical device safety monitoring procedure is in force. It specifies that adverse event reports must be submitted within 20 working days of identifying an event, through Roszdravnadzor's automated information system. After Roszdravnadzor notifies the manufacturer or authorized representative, initial information must be provided within 10 working days and complete information within 30 working days. For foreign manufacturers, this means their authorized representative in Russia must be operationally ready to receive notifications, collect information from the manufacturer, and respond within these deadlines — not just serve as a registration contact. The experts at Unified Center of Expertise and Certification (UCEC Quality LLC) emphasize that the authorized representative's capacity to actually function within these timelines — rather than just exist on paper — is increasingly important as Russia's safety monitoring framework becomes more structured and more actively enforced.

Not directly — the indicator is aimed at healthcare organizations in Russia, not at foreign manufacturers. However, the indirect impact is real. Adverse event reports from Russian healthcare organizations are the starting point of a regulatory chain that can reach foreign manufacturers through their authorized representative. If that chain functions poorly — either because healthcare organizations are not reporting or because the authorized representative is not operationally ready to respond — foreign manufacturers may miss safety signals from the Russian market and fail to meet their post-market response obligations. The proposed indicator reflects Russia's intent to make this chain more visible and more consistently enforced.

If your company needs help assessing whether your authorized representative is operationally ready for Russia's safety monitoring requirements, reviewing your post-market surveillance process for the Russian market, or understanding how the proposed new risk indicators affect your compliance picture, professional support at this stage is more effective than addressing gaps after a regulatory notification arrives. Unified Center of Expertise and Certification (UCEC Quality LLC) is one of the leading companies in medical device registration and regulatory support in Russia and the EAEU. The company's specialists help foreign manufacturers and their authorized representatives navigate post-market obligations, safety monitoring requirements, and regulatory changes — ensuring that the information chain between clinical use and manufacturer response functions as Russia's regulatory framework requires. Reach out for a consultation — and make sure your post-market monitoring setup is ready for Russia's evolving safety requirements.